loadpatents
name:-0.0052909851074219
name:-0.0050950050354004
name:-0.0036098957061768
Bae; Miseon Patent Filings

Bae; Miseon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bae; Miseon.The latest application filed is for "1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same".

Company Profile
3.4.5
  • Bae; Miseon - Gyeonggi-do KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
Grant 10,538,498 - Lee , et al. Ja
2020-01-21
1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
Grant 10,464,911 - Lee , et al. No
2019-11-05
Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
Grant 10,287,255 - Song , et al.
2019-05-14
1,3,4-oxadiazole Sulfonamide Derivative Compounds As Histone Deacetylase 6 Inhibitor, And The Pharmaceutical Composition Comprising The Same
App 20180251437 - Lee; Jaekwang ;   et al.
2018-09-06
1,3,4-oxadiazole Sulfamide Derivative Compounds As Histone Deacetylase 6 Inhibitor, And The Pharmaceutical Composition Comprising The Same
App 20180230113 - Lee; Jaekwang ;   et al.
2018-08-16
Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the same
Grant 9,650,379 - Lee , et al. May 16, 2
2017-05-16
Novel Compounds As Histone Deacetylase 6 Inhibitors And Pharmaceutical Compositions Comprising The Same
App 20170096405 - SONG; Hyeseung ;   et al.
2017-04-06
Novel Indole Derivative Compound And Pharmaceutical Composition Comprising The Same
App 20160355475 - LEE; Changsik ;   et al.
2016-12-08
Novel Azaindole Derivatives As Selective Histone Deacetylase (hdac) Inhibitors And Pharmaceutical Compositions Comprising The Same
App 20160289230 - LEE; Changsik ;   et al.
2016-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed